Related Experiment Videos
[Neutropenia in childhood]
A Ruggiero1, V Ridola, G Attinà
1Istituto di Clinica Pediatrica, Policlinico Universitario A. Gemelli, Roma, Italia.
Insights
Pediatric neutropenia, a common issue, ranges from mild to severe. Understanding the cause is key to effective treatment, including options like rhG-CSF.
Area of Science:
- Pediatric Hematology
- Immunology
Context:
- Neutropenia is a frequent condition in children.
- Management varies based on severity and etiology.
- Requires collaboration between pediatricians and hematologists.
Purpose:
- To review the causes, clinical course, and treatment of pediatric neutropenia.
- To guide clinical management strategies.
- To discuss various therapeutic options.
Summary:
- This review covers constitutional and acquired neutropenias in children.
- Etiology, clinical presentation, and management are discussed.
- Treatment options include glucocorticoids, IVIG, and rhG-CSF.
Impact:
- Provides a comprehensive overview for clinicians managing pediatric neutropenia.
- Aids in differentiating and treating various forms of neutropenia.
- Highlights the evolving therapeutic landscape, including growth factors.
Abstract:
The discovery of a neutropenia is a common problem in pediatric population. Some children with neutropenia have an uncomplicated clinical course and require no treatment. However, some patients are more severely affected and present a management challenge for the pediatrician and for the hematologist. The clinical approach to these children is directed primarily to understand the etiology of neutropenia in order to define a correct therapeutic behaviour, such as glucocorticoids, intravenous immunoglobulins or, more recently, rhG-CSF. In our article we have reviewed the etiology, the clinical course and the therapeutic options of constitutional and acquired neutropenias.